Keeping tabs on SARS-CoV-2
In the ENDVOC project we will study
variants of concern across the world
Supporting the global response to COVID-19 and future pandemics
We will evaluate the impact of different variants in
diagnostics, treatment, and public health strategies
By investigating the circulation and impact of current and emerging
SARS-CoV-2 variants of concern (VOC), we aim to evaluate and
support effective pandemic responses. To do so, we will use data from
well-established patient and population cohorts across the world.
” Detecting emerging Covid-19 variants of concern, and understanding their
implications on diagnostics, vaccination strategies and treatment options
is key to guiding our response to the virus”
Ibrahim Abubakar, principal researcher of the project based at UCL
ENDVOC in numbers
Our project at a glance
19
Partners
23
Countries
28
Cohorts
5
Key research
questions
What’s new
Keep track of our activities and results
Mpox Outbreak in Africa Can Still be Controlled and Eliminated, Says END-VOC Leader
In a recent comment published in The Lancet, Ibrahim Abubakar and colleagues stress the importance of African leadership in effectively responding to the ongoing mpox outbreak […]
END-VOC Welcomes a New Partner to the Project
This summer, the Instituto de Medicina Molecular (IMM) Joao Lobo Antunes officially joined the ENDVOC project. In an interview, group leader Luis Graca explains how this partnership will allow to study the impact of COVID-19 variants among immunocompromised patients. […]
ENDVOC’s Fourth General Assembly in London Shows Great Progress
The ENDVOC consortium is now in a position to step up its cross-cohort analyses and to help fill gaps in key areas such as Long Covid and pandemic preparedness […]
